All In MedTech

Device Trial Radar · NCT03605823

Pars Plana Ex-Press Shunt in Vitrectomized Eyes

Pars Plana Ex-Press Mini Shunt for Management of Persistent Glaucoma in Vitrectomized Eye. A Potential Novel Technique.

Last checked: Nov 19, 2026Latest source record: Apr 19, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

20

Planned (sponsor's estimate)

Start

Nov 1, 2017

Primary completion

Nov 1, 2019

Study completion Nov 1, 2019

Sponsor

Lead sponsor
Cairo UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 30, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Implantation of Ex-Press Minishunt via the pars plana in treatment of secondary glaucoma in vitrectomized eyes achieves promising results avoiding complications of other surgical modalities.

Conditions

  • Glaucoma Secondary

Interventions

  • Express Mini shuntDevice

    Implantation of Express Mini shunt through pars plana in vitrectomized eyes

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Intraocular pressure control (IOP)Time frame: 6 month

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Cairo University

    Cairo, Egypt · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.